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Abstract Claudins are a large family of membrane proteins
whose classic function is to regulate the permeability of tight
junctions in epithelia. They are tetraspanins, with four alpha-
helices crossing the membrane, two extracellular loops, a short
cytoplasmic N-terminus and a longer and more variable C-ter-
minus. The extracellular ends of the helices are known to un-
dergo side-to-side (cis) interactions that allow the formation of
claudin polymers in the plane of the membrane. The extracel-
lular loops also engage in head-to-head (trans) interactions
thought to mediate the formation of tight junctions. However,
claudins are also present in intracellular structures, thought to be
vesicles, with less well-characterized functions. Here, we brief-
ly review our current understanding of claudin structure and
function followed by an examination of changes in claudin
mRNA and protein expression and localization through mam-
mary gland development. Claudins-1, 3, 4, 7, and 8 are the five
most prominent members of the claudin family in the mouse
mammary gland, with varied abundance and intracellular local-
ization during the different stages of post-pubertal develop-
ment. Claudin-1 is clearly localized to tight junctions in mam-
mary ducts in non-pregnant non-lactating animals. Cytoplasmic
puncta that stain for claudin-7 are present throughout develop-
ment. During pregnancy claudin-3 is localized both to the tight
junction and basolaterally while claudin-4 is found only in
sparse puncta. In the lactating mouse both claudin-3 and
claudin-8 are localized at the tight junction where they may
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be important in forming the paracellular barrier. At involution
and under challenge by lipopolysaccharide claudins −1, −3, and
−4 are significantly upregulated. Claudin-3 is still colocalized
with tight junction molecules but is also distributed through the
cytoplasm as is claudin-4. These largely descriptive data pro-
vide the essential framework for future mechanistic studies of
the function and regulation ofmammary epithelial cell claudins.
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Part 1. An Overview of Claudin Structure
and Biology
Introduction The claudin family comprises a large class of
transmembrane proteins whose activity was first described in
1998 by Tsukita and colleagues who showed that claudin-1
and claudin-2 are important participants in tight junctions [1],
interacting between cells to form the apical barrier that controls
epithelial permeability (Fig. 1a). At least 63 different claudin
family members have been identified since their initial dis-
covery [2]; about 27 of these molecules are thought to be
present in humans [3]. All are tetraspanins with four trans-
membrane domains, intracellular N and C termini, and two
extracellular loops (Fig. 1c). Early studies from the Tsukita
laboratory showed that expression of claudin-1 or claudin-
2 in cultured fibroblasts leads to formation of continuous
interacting polymeric rows of claudin similar to the poly-
meric claudins observed in epithelial tight junctions [4],
providing positive proof of the importance of claudins in
these structures. Genomic knockdown of claudin-1 in mice
led to death at birth due to defects in the epidermis estab-
lishing that claudins are important in both mucosal and
epidermal barriers [5].
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Fig. 1 Localization and molecular structure of claudins. a Model
mucosal epithelial layer showing apical location of tight junctions. b
Aqueous pores formed by some claudins in the tight junction provide a
pathway for paracellular ionic flux. c. Diagrammatic view of a claudin
molecule in the plasma membrane showing the four transepithelial
regions, the two extracellular loops (ECS) and the cytoplasmic N and C
termini. a,b,c, from [23], Current Opinion in Cell Biology. d Detailed
crystal structure of the claudin-15 molecule showing its orientation in
the plasma membrane, represented by grey rectangles; image from ref.
[76], Science; used by permission. Transmembrane segments (TM) are
shown as alpha-helices with TM1 in blue, TM2 in green with the four
beta-sheets of extracellular loop 1 between them. TM3 is yellow with the
helix extending beyond the membrane into the interstitial space; TM4 is
red and ECL2 is between TM3 and TM4 and contains one beta-sheet. The
C-terminus of the molecule was removed to facilitate crystallization and
is not shown. e Claudins are thought to polymerize in the membrane via
interactions between amino acids on membrane adjacent portions of
ECL1 (bright green) and ECL2 (red). Image shows claudin-15 polymer
with extracellular side (e), cytoplasmic side (c), andmembrane (m) Image
from [10], The Biochenical Journal. f Immunofluorescent localization of
claudin-4 in subconfluent cultured primary mammary epithelial cells.
Upper image, colocalization of claudin-4 (red) with the tight junction
protein ZO-1 (green) and nuclei (blue). Claudin-4 is colocalized with
ZO-1 in the tight junctions; it is also present as cytoplasmic puncta and
in cellular projections that show no sign of ZO-1 staining. Image from ref.
[18], BMC Cell Biology
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Claudins have been most studied as components of the
epithelial tight junction where they can inhibit transcellular
permeation of small molecules or form specific channels al-
low flux of anions or cations across the paracellular space of
the epithelium (Fig. 1b). In particular, claudins-2, −10b, and
−15 have been shown to mediate cation permeation, while
claudins-10a and -17 mediate anion permeation [6, 7].
Claudin-2 also allows water to permeate the epithelial barrier
[6]. The crystal structure of pore forming claudin-15 has re-
cently been published [8] showing that the four transmem-
brane (TM) segments of the molecules form alpha-helices
while extracellular loop 1 (ECL1), involved in intercellular
interactions, possesses four beta-pleated sheets and the smaller
extracellular loop 2 (ECL2) has one (Fig. 1c, d). Studies of
claudin-4 bound to the Clostridium perfringens endotoxin
(CPE) are consistent with this structure [9]. Elegant studies
of interacting molecules using FRET technology have shown
that claudins possess both side-to-side (cis) interactions with
other claudins in the samemembrane and head-to-head (trans)
interactions with claudins in adjacent cells [10].
X-ray crystallographic studies of the binding of
Clostridium perfringens endotoxin (CPE) with claudin-19
[9, 11] shed light on the cis interactions: in this claudin the
leucine on TM segment 1 interacts hydrophobically with phe-
nylalanines on TM1 and TM3 on an adjacent molecule
(Fig. 1e). Five amino acid peptide mimics to the extracellular
helix of TM3 in claudins-3 and -4 disrupted epithelial perme-
ability and claudin-4 localization in cultured Eph4 mammary
epithelial cells (peptide sequence DFYNP, amino acids 146–
150 on TM3) [12]. Recent work from the Kovak laboratory
showed that lung alveolar epithelial cells isolated from alcohol
treated rats contain claudin-5, a molecule usually found in the
endothelium [13]. Treatment of these cells with a peptide
mimic to the same TM3 locus on claudin-5 (peptide sequence
EFYDP) decreased trans-epithelial resistance and increased
the permeability of large molecules when these cells were
grown on Transwell permeable filters [14]. These independent
findings using two peptides targeting two different claudins
indicate that cis interactions of the claudin molecule are im-
portant in maintaining tight junction structure.
Claudins also engage in interactions with the cytoskeleton
mostly through the YV-amino acid motif at the C-terminus of
most claudins. This motif allows interactions with PDZ do-
main containing proteins such as ZO-1-2, and −3, compo-
nents of the tight junction [15]. These molecules in turn bind
to the actin cytoskeleton and to regulatory molecules which
control not only tight junction formation but also cell polarity,
migration, proliferation and apoptosis [16]. As an example,
we have shown that treatment of cultured cells with the
DFYNP peptide, mentioned above, decreases cell motility
and increases apoptosis through the FAS-dependent extrinsic
pathway [12, 17, 18]. Another tetraspanin, occludin, is exclu-
sively localized to the tight junction in normal epithelia, but
its function is not entirely clear as occludin knockout mice
survive with intact epithelial structures [19]. Altogether the
claudin family of tetraspanin proteins provides important ep-
ithelial barrier functions; emerging evidence reviewed below
indicates they may also participate in additional intracellular
and extracellular interactions.
Tissue Expression Patterns of Claudins Figure 1f showing
claudin-4 localization in subconfluent cultured primary mam-
mary epithelial cells illustrates the complexity of claudin lo-
calization. In cultured cells the molecule does colocalize with
ZO-1 in tight junctions. However, it is also clearly seen in
small cytoplasmic puncta and in projections from the cell
reaching out both to the extracellular matrix and to an adjacent
cell. This image raises several important questions about
claudin function to which we do not have satisfactory an-
swers. We briefly summarize claudin expression and localiza-
tion in several epithelial tissues in this introduction providing
a cell biological background for more detailed analysis of our
current understanding of claudin expression and localization
in the mammary gland.
Epithelial claudin composition changes both with differen-
tiation and position in mucosal organs, a process termed
Bclaudin switching^ by Capaldo andNusrat [20]. In the kidney
claudin localization was determined by co-immunostaining
with segment-specific molecules such as aquaporins-1 and -
2; a very complex distribution was observed depending on the
segment of the renal tubule [21, 22]. For example, while
claudin-2 was found in most segments, claudin-16, which
has been associated with diseases of magnesium transport
[23], was present only in the thick ascending limb of the loop
of Henle. The distribution of claudin-10 depended on isoform:
isoform 10a formed a paracellular channel permeable to anions
whereas isoform 10b formed a cation-selective channel [7]. In
the digestive system claudin-3 was localized to the tight junc-
tions of the intestinal epithelium and the liver, while claudin-4
was found at junctions in the epithelium of the stomach and
colon [24]. In addition some claudins have been shown to be
localized in cytoplasmic Bdots^ or puncta, presumably vesi-
cles, distributed in the cytoplasm [3]. For example, claudin-3
appeared to be extra-junctional in the stomach and duodenum
as well as the pancreas [24] and claudin-4 wasmainly localized
apically in small intestinal cells preparing to slough into the
lumen and demonstrating little overlap with the tight junction
marker ZO-1. In the epididymis claudin-1 was found in the
lateral and basal borders of the principal cells; electron micro-
scopic images showed it to be localized at tight junctions,
along lateral borders and, unexpectedly, associated with the
basement membrane [25].
While the tight junction claudin pool has received the most
attention, many cells have two or more pools of claudins; the
tight junction pool and a cytoplasmic pool often observed as
puncta, presumably vesicles, distributed at the basolateral
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borders of the cell [26]. The first clear demonstration of cyto-
plasmic claudin-3 was in Eph4 and MDCK cells transfected
with GFP-NClaudin-3, where both native claudin-3 and GFP-
Nclaudin-3 were found both in tight junctions and in what the
authors designated as cytoplasmic granules, postulated to be
vesicular structures [27]. Some of these granules appeared to
originate from endocytosis of tight junction claudin-3; in some
cases the granules were associated with late lysosomal
markers. In studies of Clostridium perfringens endotoxin
binding to claudin-3 in HEK cells, CPE was found to bind
to claudin-3 on cell surfaces, not associated with the tight
junction [28]. This finding suggests that non-junctional
claudin in epithelial cells cycles to the cell surface indepen-
dent of tight junction interactions and may not simply reflect
transport to and from the tight junctions.More recent work has
shed some light on the interactions of non-junctional claudins-
4 and -7 with intracellular and membrane proteins as we will
elaborate below.
As will be shown in detail in later sections of this paper
the classical claudins-1, -3, -4, -7, -8, all non-pore-
forming claudins, are present at various times and cellular
positions in the mammary epithelium showing marked
developmental switching. Claudins-1, -3 and -8 are clear-
ly localized to tight junctions at various stages of mam-
mary development. However, claudins-3, -4 and -7 are
also present at the basal and lateral surfaces of the ductal
epithelial cells where they can be seen as cytoplasmic
puncta not colocalized with the tight junction protein
ZO-1. We briefly review work from other tissues that
sheds some light on the interactions and functions of these
non-junctional claudins. We start with claudin-7 where the
most definitive work is available, then continue to
claudins-3 and -4.
Claudin-7Although transduced claudin-7 has been shown to
form polymerized rows in S7 cells, a fibroblast line lacking
tight junctions, in vivo the molecule was generally not asso-
ciated with tight junctions but was found in cytoplasmic
puncta, which are likely to be vesicles [29, 30]. We and
Kobayashi showed previously that claudin-7 is present in
alveolar cells at all stages of mammary development [29,
31] localized to basolateral surfaces as it is in many other
tissues like the epididymis and intestine [30, 32, 33].
Recently, claudin-7 was shown to complex with EpCAM,
an epithelial adhesion molecule enriched at the basolateral
membrane of intestinal and other cells [34]. When EpCAM
was knocked down in intestinal cells, the small amount of
claudin -7 remaining was localized to tight junctions. More
recent work from the Thuma laboratory [35, 36] clearly
showed that palmitoylated claudin-7 recruits EpCAM to
glycolipid-enriched membrane domains, often designated as
lipid rafts. Only when a mutation that prevents palmitoylation
of claudin-7 was present, did the protein associate with tight
junctions. Studies of intestinal architecture in claudin-7
knockout mice led Ding and associates [33] to conclude that
claudin-7, interacting with EpCAM and integrin-α2 mediates
lateral cell-cell interactions as well as interactions with the
cell-matrix.
Non-junctional Claudins-3 and -4 Workers in the Tsukita
lab found more than a decade ago that claudins-3 and -4
could be localized in cytoplasmic vesicles whose presence
was apparently related to cell motility [27]. In most cells
and tissues claudin-3 has been almost exclusively de-
scribed as being part of the tight junction; however, it is
notable that during maturation of the murine intestine dur-
ing the first 3 weeks of life basolateral claudin-3 increases
simultaneously with its localization at the apical membrane
of the intestinal cells [37]. In the colonic epithelium of
mature C57Bl/6j mice claudin-3 is localized entirely at
the basolateral membrane [38]. Because claudin-3 has been
seen to move in and out of the tight junctions [20], cyto-
plasmic vesicles have often been considered as storage
depots for tight junction claudins.
Similarly, in MDCK cells claudin-4 is found both at
tight junctions and in discrete cytoplasmic structures.
Biotin ligase fused to the N-terminus of claudin-4 or to
the tight junction protein occludin, was used to biotinylate
proteins proximal to both occludin and claudin-4 followed
by purification of biotinylated proteins and identification
by mass spectrometry [39]. Using the data from this study
of MDCK cells we have divided the biotinylated proteins
into two categories: Category 1 contains proteins that were
biotinylated when biotin ligase was fused to either
occludin or claudin-4, presumably identifying proteins as-
sociated with the tight junction. Category 2 contains pro-
teins only biotinylated when biotin ligase was fused to
claudin-4. Interestingly, category 1 includes vesicle pro-
teins involved in fusion with the plasma membrane in the
neuronal synapse: synaptobrevin like protein YKT6-like,
vesicle associated membrane protein VAMP-2, vesicle as-
sociate membrane protein VAMP-5, synaptosomal associ-
ated protein SNAP-23, a regulatory factor and syntaxins-6
and-8. CAR (coxsackievirus and adenovirus receptor ho-
molog) is also included in this category. These observa-
tions suggest that synaptic-like vesicles may be involved
in claudin cycling to the tight junction as proposed by
Nusrat and colleagues in a symposium article reporting
that SNARE proteins may be associated with recycling of
tight junction molecules [40]. In addition recent compre-
hensive experiments showed that syntaxin-8 binds to
claudin-16 and promotes the exocytosis of claudin-16 from
subcellular compartments to the tight junctions [41]. The
distribution of SNARE proteins in the lactating mammary
epithelium has recently been summarized [42], how this
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distribution relates to claudin distribution is a subject for
future research.
Category 2 proteins include Rab7a as well as cell adhesion
molecules, CD44 antigen, CEA1, integrins β and α2 and
cytoskeletal related proteins BAI1 andMarcks-related protein.
These findings lead to a second hypothesis that claudin-4 lo-
calized to cytoplasmic vesicles is involved in cell-cell and
cell-matrix interactions, potentially placing claudins as inte-
grators of both cell-extrinsic and cell-intrinsic signal transduc-
tion pathways. This hypothesis is supported by the finding in
cultures of normal and T47D breast cancer cells cultured on
collagen that knockdown of claudin-4 or treatment with the
claudin disrupting peptide DFYNP decreased cell motility and
increased apoptosis [18]. To further test this hypothesis local-
ization of claudins during the various stages of mammary
development as well as identification of interacting proteins
will be necessary. In the next section we provide a compre-
hensive review of claudin expression and localization during
mammary development; work on interacting proteins remains
for the future.
Part 2: Claudin Expression and Localization
during Mammary Gland Development
Because the role of claudins in mammary development has
been extensively studied in the mouse, and considerable pub-
lished data is available from both the Kobayashi [31, 43] and
the Neville [12, 29, 44–47] laboratories on tight junction func-
tion and claudins, we focus on murine data in this paper. Here
we combine published data from these and other laboratories
with unpublished data from the Neville laboratory offering a
descriptive framework that should foster future mechanistic
studies on claudin regulation and function throughout mam-
mary development.
Claudin mRNA Expression during Development in the
Murine Mammary Gland Published work from the Neville
laboratory [29] showed the expression of claudin-7 mRNA
through development (Fig. 2a). The expression of both
claudin-7 and keratin 19, a marker of alveolar epithelial cells
in the mammary gland, was analyzed by quantitative PCR
Fig. 2 Developmental expression of claudin mRNA in the murine
mammary gland. a Developmental expression of claudin-7 compared to
expression of the epithelial keratin 19 in glands of CD1 mice using real
time PCR. Graph from Reference [29] Breast Cancer Research. b, c.
Time course data obtained from Affymetrix arrays (MG-U74Av2–able
to hybridize 12,000 genes) performed in the Gusterson [48] and Neville
[49] laboratories. Data are combined to demonstrate how these claudins
vary through the reproductive cycle. V, glands isolated from non-pregnant
non-lactating mice at 4, 6, 10 and 12 weeks after birth. P (pregnancy),
glands isolated 0, 1, 2, 3, 7, 10.5, 12, 14.5, 17 and 19 days after mating.
Birth occurs about 19.5 days after mating in these two strains. L
(lactating), glands isolated at 1, 2, 3, 7 and 9 days after parturition. I,
(involution) glands 1, 2, 3, 4 and 20 days after pup removal on day 8
([48]) or 10 ([49]) of lactation. b. Expression of claudins-2, 5, 6, and 11
compared to that of claudin-7. c.Expression of claudins-1, −3, −4, and −8
as indicated
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(qPCR). The parallel expression of the two genes suggests that
claudin-7 expression can be used as a marker of the proportion
of the tissue occupied by epithelial cells. These data indicate
that the proportion of epithelial tissue increases about 1000-
fold between the virgin and lactating states, an important con-
sideration when whole mammary tissue is being analyzed for
mRNA or protein.
Two previously published microarray studies using RNA
extracts from whole tissue [48, 49] provide an overall picture
of epithelial claudin mRNA expression as the murine mam-
mary gland passes from the virgin state, through pregnancy,
lactation and involution (Fig. 2b, c). Figure 2b shows three
claudins (-2, -6, -11) expressed at low and invariant levels
through development compared to the expression of
claudins-5 and -7. There is no evidence that claudin-2, 6 and
-11 proteins are found in the mammary gland. Claudin-5 is
confined to the endothelium in most tissues [13]; we have not
been able to observe it within the mammary epithelium (un-
published data). Claudin-7 expression was consistent with our
previous findings [29]. Claudin-1 (Fig. 2c) mRNA was
expressed at a relatively constant level throughout the repro-
ductive cycle. Claudin-3 mRNA expression roughly
paralleled that of claudin-7 in glands from virgin and pregnant
animals. Its expression fell about 8-fold at the onset of lacta-
tion possibly reflecting the loss of non-junctional claudin-3; it
still remained at a relatively high level through lactation as
expected from its localization at tight junctions (see below).
It rebounded with involution. Claudin-4 was expressed at
modest levels in the glands from virgin and pregnant animals,
falling to almost undetectable levels during lactation; it in-
creased more than 10-fold after pup removal. Claudin-8 has
been little studied but levels of its mRNA increased about 30-
fold between the virgin and lactating state; it remained high
through lactation and decreased with cessation of milk secre-
tion. Levels of claudins-1, -3, -4 and -7mRNA, as well as their
protein levels, measured by the Plante laboratory over murine
mammary development [50], are consistent with the values
shown in Fig. 2.
Claudin Localization in Mammary Glands of Non-
Pregnant, Non-Lactating Animals Mammary development
begins at puberty with estrogen-stimulated ductal lengthening
and branching [51]. Claudin-1 was located at the tight junc-
tions of the mammary ducts [29, 52–54] (Fig. 3b), presumably
restricting paracellular permeability although no permeability
data appear to be available. Claudin-1 has been clearly ob-
served inmammary epithelia from 35 day old rats as well [54].
Claudins-3, -4 and -7 were observed as cytoplasmic puncta
at the basal and lateral surfaces of ductal epithelial cells in
sections frommammary glands of non-pregnant non-lactating
mice (Fig. 3a). The most intense claudin-3 stain was seen in
regions near the basolateral membrane showing minimal over-
lap with the tight junction protein ZO-1 (Fig. 3c). Distinct
claudin-3 puncta could also be seen in the perinuclear regions.
Claudin-4 was present only in lightly-stained sparse intracel-
lular puncta (Fig. 3d). Again overlap with ZO-1 was minimal.
As shown previously [29], claudin-7 was not associated with
ZO-1 (Fig. 3e). Together, these observations indicate that
extra-junctional patterning of claudin-3, -4, and -7 is common
in the mammary epithelium and suggest that claudins-3, -4
and -7 are likely to have a function other than sealing of the
tight junction.
Claudins-1, -3, -4 and 7 are the four most studied claudins
in normal mammary glands of humans [52] and other animals.
Kominsky et al. [55] saw little claudin-3 and claudin-4 in
tissues adjacent to breast tumors in the human mammary
gland but Tokes et al. [52] found that these claudins were often
present in the normal breast. In normal human breast tissue
adjacent to breast cancer lesions claudins-1 and -3 were clear-
ly localized apically with some basal staining by immunoflu-
orescence [56]. In canine mammary glands the mRNA for
CLDN-1 and -7 were the most highly expressed with
claudins-3 and -4 moderately lower [53]. Cellular localization
of these canine claudins was unexpectedly found to be along
the entire lateral area of the epithelial cells and not just at the
apical border. Plante and colleagues observed basolateral
staining of claudins-3 and -7 in mammary glands from virgin
mice with apical localization only at pregnancy day 18 [50].
Claudin Expression and Localization in Mammary
Glands from Pregnant Mice Increases in progesterone as
pregnancy commences stimulate alveolar proliferation follow-
ed by differentiation, a process also stimulated by placental
lactogen (and prolactin in humans) [57]. To validate the ex-
pression of mammary claudins, mammary alveolar epithelial
cells (MEC) were isolated [58] from the mammary glands of
pregnant day 13.5 and lactation day 2 FVB mice and gene
expression evaluated by advanced microarray analyzing near-
ly 30,000 genes (Fig. 4a). As previously observed (Fig. 2) the
mRNA for claudins-1, -3, -4, -5, -7, and -8 were found to be
present at significant levels in pregnancy or lactation or both.
The non-canonical claudins-12 and -25 were also expressed at
levels above background in both pregnancy and lactation with
significant increases during lactation. There is a little data on
mammary claudin-12; it showed weak cytoplasmic staining in
normal breast cells adjacent to breast tumors, but was upreg-
ulated in some tumors [59]. Its expression increased MCF-7
cell migration [60], but nothing is currently known about its
function in the normal mammary epithelium. This is the first
report of claudin-25 in the mammary gland and nothing more
is known at this writing.
Secretory activation is set in motion by a decrease in pro-
gesterone associated with parturition and has been shown to
require both prolactin and glucocorticoid signaling [61].
Figure 4b shows detailed changes in expression of classical
claudins around parturition in the mouse; the use of qPCR
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allows comparison of expression levels. Close examination
shows that the transition to lactation levels for most of these
genes starts at pregnancy day 18.5, just when progesterone
falls. At mid-pregnancy claudin-3 mRNA was present at the
highest levels. The protein showed heavy basolateral staining
in both early and late pregnancy (Fig. 3c–e). By pregnancy
day 17 it was also localized with ZO-1 (CD1 mice, Fig. 4d) or
occludin (ICR mice, Fig. 4g, ref. [43]). Claudin-4 mRNAwas
much lower and fell almost 100 fold on P18.5. The protein
was present as sparse cytoplasmic puncta at P7. The mRNA
for claudin-5, the endothelial protein, fell in early lactation
probably reflecting the decrease in the amount of adipose tis-
sue, which is heavily vascularized. Claudin-7 mRNA
remained approximately constant and continued to be local-
ized basolaterally (Fig. 4f). Claudin-8 was fairly low at mid-
pregnancy but rose 10-fold by P18.5 and another 3-fold in
early lactation to become the most highly expressed claudin
gene. We show in the next section that it is localized at the
tight junction suggesting that it may help establish the
paracellular barrier present in the lactating gland [62].
Claudins in the Lactating Mammary Gland The analyses
of claudin mRNA in the mammary glands from lactating mice
(Fig. 2, Fig. 4a, b) suggested that the most important epithelial
claudins at this time are claudins-3, -7, -8. The mRNA for
claudin-3 fell about 10-fold at the onset of lactation, but was
still present at significant levels. ThemRNA for claudin-7 was
maintained at high levels throughout. The mRNA for claudin-
8 increased more than 25-fold to become the most highly
expressed claudin mRNA in the lactating gland (Fig. 4b).
e CLDN7 ZO-1
CLDN7
ZO-1
b CLDN1 ZO-1
ZO-1
CLDN1
c CLDN3 ZO-1
CLDN3
ZO-1
d  CLDN4  ZO-1
CLDN4
ZO-1
Merge 
Nuclei 
Claudins 
Claudins 
Magnified 
a CLDN3       CLDN4      CLDN7
Fig. 3 Immunofluorescence analysis of claudins in the mammary gland
of the non-pregnant, non-lactating mouse. a. Immunofluorescence
analysis of Claudins-3, −4, and −7 in mammary glands of the FVB
mouse highlighting the punctate nature of the stain localized in the
ductal cells. b, c, d. Immunofluorescent images of ductal sections
mammary glands from CD1 virgin mice stained for claudins-1, −3, −4
respectively (red stain) and the tight junction protein ZO-1 (green). b.
Claudin-1 overlapped heavily with ZO-1, appearing yellow in merged
images, indicating association with tight junctions in this ductal section.
c. Claudin-3 was heavily stained along lateral and basal borders but
showed little overlap with ZO-1. d. Claudin-4 was observed as sparse
cytoplasmic puncta, again with little overlap with ZO-1. e. Claudin-7 was
localized along the basal and lateral border of the ductal cells in the CD1
mouse with little or no overlap with ZO-1 See also ref. [29]. Scale bars,
20 μm. See Methods section for tissue preparation and staining methods
for all these figures
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Western blots from the Kobayashi laboratory [43] showed
that claudin-3 protein in the late pregnant and lactating gland
is relatively constant, whereas claudin-4 protein decreased
rapidly after the onset of lactation (Fig. 5a, b). The presence
f--P7e--P7 g--P17
CLDN7 ZO-1  DAPICLDN4 ZO-1 CLDN3 OCLN DAPI
LUMEN 
c--P7 d--P17
CLDN3 ZO-1 DAPICLDN3 ZO-1  DAPI
CLDN3
ZO-1
CLDN3 
ZO-1
a b
LUMEN 
Fig. 4 Expression and localization of claudins in pregnancy. a.
Microarray analysis of claudin mRNA in MECs isolated from pregnant
(day 13.5) and lactating (day 2) FVBmice [58]. MECswere isolated from
the 4th mammary gland according to the techniques of Rudolph and
colleagues [58]. mRNA expression was analyzed using Affymetrix
MoGene_1_0-st-v1 chip arrays [77]. Raw expression values for all
claudins with expression values above 40 (dotted line) at pregnancy day
13.5 (red) or lactation day 2 (blue) are shown. * Expression significantly
different between pregnancy and lactation, P < 0.05 b. mRNA expression
of claudins 1, 3, 4, 5, 7 and 8 during the transition from pregnancy to
lactation by quantitative real time PCR using lysates of whole mammary
glands (See Methods, Fig. 4). d,e. Immunofluorescence localization of
claudins-3, −4 and −7 in mammary glands from CD1 pregnant mice
(Neville laboratory, see Methods section). c,e,f. Pregnancy day 7.
Similar results were observed in both formalin-fixed (shown) and
frozen (not shown) sections. d,g. Pregnancy day 17. g. Localization of
claudin-3 in the mammary gland from the ICR mouse; in this strain
claudin-3 was localized both basolaterally and with occludin at
pregnancy day 17 [43]. c-g. Scale bars, 20 μm
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of a higher molecular weight form of claudin-3 during lacta-
tion suggests that phosphorylation, possibly on threonine 192
[63], or palmitoylation [36], may be important for tight junc-
tion sealing. The nature of this higher molecular weight form
requires more investigation. Immunofluorescence analyses
showed claudin-3 localized to tight junctions during lactation
(Fig. 5c) [31, 64]. The basolateral claudin-3, present in preg-
nancy, was no longer apparent. Claudin-4 was largely absent
from the lactating epithelium (Fig. 5c) except for very occa-
sional cells showing strong basolateral staining (Fig. 5e). As at
other stages claudin-7 was found in puncta near the basal and
lateral borders of the alveolar epithelial cells from both the
Neville [29] and Kobayashi [31] laboratories (not shown).
Claudin-8 protein, shown to reduce paracellular permeability
in kidney cells [65], was localized with ZO-1 in the lactating
gland (Fig. 5d). Together these findings lead to the hypothesis
that junctional claudins-3 and -8 are responsible for the very
low paracellular permeability of the lactating mammary gland
[66]. Both the regulatory molecules pSTAT5a and the gluco-
corticoid receptor (GR), thought to be important controllers of
milk secretion [67, 68], were associated with nuclei only in
sections from the lactating gland (Fig. 5c).
The next question was how the changes in claudin expres-
sion and localization in lactation relate to the hormonal influ-
ences that set mammary functions like casein synthesis and
milk secretion in motion at parturition. Primary cells (MEC)
were isolated from the mammary glands of virgin ICR mice
and maintained in culture [64], In the MEC without hormones
epithelial permeability was low and little claudin-3 and
claudin-4 was localized to the tight junction. Addition of
glucocorticoid alone promoted the barrier function of the ep-
ithelium and both claudins-3 and -4 were localized to the tight
junction. When prolactin was added alone both claudins de-
creased and some claudin-3 appeared to move into the tight
junctions. Addition of both hormones together led to in-
creased localization of claudin-3 with occludin at the tight
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Fig. 5 Protein expression and localization for claudins in the mammary
gland of mice in mid-lactation. a Western blots for claudins-3 and -4 in
the lactating gland at days 0, 1, 5, and 10 compared to late pregnancy
(P17). Alpha-tubulin was the loading control. b Quantitation of Western
blots for claudin-3 and claudin-4 compared to late pregnancy (P17).
Significantly different from P17, *P < 0.05; **P < 0.01. c. Subcellular
localization of claudins-3 and -4, pSTAT5a and the glucocorticoid
receptor (GR) in the murine mammary gland at day 10 of lactation.
Paraffin sections were immunostained with antibodies to the relevant
claudin (green), occludin (red), pSTAT5a (red) and GR (green). Blue;
nuclei stained with DAPI. d Immunofluorescence analysis of claudin-8
from the mammary gland of a day 2 lactating mouse. e. Rare occurrence
of basolateral CLDN4 in a mammary alveolar cell of a lactating mouse.
Scale bars; 20 μm. Images a and b based on ref. [43], image c based on
Ref [64] and image e from Ref [31] Plos One, all ICR mice. Image d,
Neville laboratory (CD1 mouse; see methods)
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junctions and a marked decrease in claudin-4. β-casein was
increased substantially by the addition of both hormones. The
effect of glucocorticoid alone could be mimicked in the lac-
tating gland by systemic administration of the inhibitor of
prolactin secretion, bromocriptine. β-casein decreased to
about 30% of the level observed at full lactation, claudin-3
and claudin-4 protein increased; both were localized to the
cytoplasm. These results, modelled in Fig. 6 show definitive-
ly that claudin protein expression and localization are under
the control of the same hormones that sustain milk secretion
during lactation. Whether Stat5a and glucocorticoid signaling
interact directly or indirectly with the regulation of the ex-
pression of the mRNA for claudins-3 and -4 is a question for
future research.
Claudins in the Involuting Mammary Gland The array
analyses in Fig. 2c showed a remarkable increase in the
mRNA for claudins 3 and 4 during the first few days of mam-
mary involution in the mouse, while claudin-7 mRNA
remained constant. Quantitative real time PCR data from the
Myal laboratory [69] showed a similar pattern for claudins-3
and -4 as does protein abundance in studies from the
Kobayashi laboratory (Fig. 7a) [43]. Claudin-3 continued to
localize with occludin during early involution, although it de-
clined in abundance after days 5 and 10 (Fig. 7b). Claudin-4,
not visible in the lactating gland, rose rapidly in abundance on
day 1 of involution when it was localized around the basal-
lateral surfaces of most cells (Fig. 7c); it continued to surround
selected cells at 5 and 10 days of involution. Higher resolution
images from the Neville laboratory (Fig. 7d) of the gland two
days following forced involution showed significant cytoplas-
mic claudin-3 and claudin-4 with little overlap with the tight
junction protein, ZO-1. Cumulative analyses of mRNA and
protein for claudin-3 and claudin-4 from five different
laboratories [29, 31, 48, 50, 69] using four different strains
of mice are congruent in that these two proteins increase sub-
stantially shortly after cessation of milk removal. In addition,
both proteins are largely localized to the cytoplasm in studies
from both the Neville and Kobayashi laboratories (Fig. 7b-d).
As we will see in the next section, similar changes were ob-
served after an inflammatory challenge. Stein and colleagues
found significant upregulation of the LPS-binding protein as
well as immune related genes during involution leading them
to suggest that involution represents a process akin to wound
healing, a concept reinforced more recently by Schedin and
colleagues [48, 70]. This concept is further validated by the
data in the next section.
Claudin Response to Intramammary Inflammation
Injection of the E. coli endotoxin lipopolysaccharide (LPS)
into the mammary gland has been used extensively as a model
for mastitis, an inflammatory state of the mammary epithelium
[71]. To study how inflammation affects claudin distribution
and function Kobayashi and colleagues injected LPS
intraductally into the 4th mammary gland of 10 day lactating
ICR mice [31]. This treatment increased the permeability of
the mammary epithelium to albumin within 3 h and led to an
immediate decrease of high molecular weight claudin-3
(Fig. 8a). The high molecular weight form of claudin-3 was
decreased 60% 3 h after LPS injection although total claudin-3
remained relatively constant. By 12 h post injection claudin-1
and claudin-4 protein were increased more than 20 fold
(Fig. 8b). Claudin-1 was localized at least in part with
occludin (Fig. 8c). Claudin-3 appeared to remain at the tight
junction but was slightly more widely distributed than
occludin. Claudin-4 was widely distributed throughout the
cytoplasm and localized at least to some extent with occludin
and claudin-7 relocated in part from the basal and lateral
Fig. 6 Model for hormonal
regulation of claudin-3 and
claudin-4 in the lactating
mammary gland. Data from
cultures of mouse mammary
epithelial cells show that claudin-
3 and claudin-4 respond to
prolactin and glucocorticoids,
major regulators of secretory
activation in a manner similar to
casein and lipid secretion [43].
See text for details
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membranes to the apical region of the alveolar cells. In keep-
ing with their redistribution to the cytoplasm [72] claudins-1
and -4 showed progressive changes in distribution between
soluble and insoluble fractions over the 12 h after LPS injec-
tion. Claudin-7 remained largely in the soluble fraction after
LPS treatment, in keeping with its usual location in cytoplas-
mic vesicles. Whether and how these changes in claudin dis-
tribution facilitate epithelial resistance to infection and repair
is not known. Claudin-4 was elevated in many types of epi-
thelial cells undergoing repair including migrating cells in the
intestinal epithelium, wounded urothelial cells and salivary
epithelial cells (reviewed in Ref [73]). The protein was in-
creased in response to acute lung inflammation [74] and
claudin-4 knockout mice had increased susceptibility to lung
injury [75]. It appears that claudin-4 is a consistent inflamma-
tory marker, although its function in what can be regarded as
wound healing is not clear.
Conclusions and Projections The major claudins in the
mammary gland are claudins-1, -3, -4, and -7 with claudin-8
present during lactation. The distribution of these claudins
between the tight junction and the cytoplasm is modelled in
Fig. 9. In the non-pregnant non-lactating gland, both in virgin
animals and after completion of involution, claudin-1 was the
major claudin located in the tight junctions of the ductal cells.
Claudins-3 and -7 were localized to numerous cytoplasmic
puncta; claudin-4 was present as sparse puncta. During preg-
nancy claudin-3 moved to the tight junctions but was also
present as a dense system of cytoplasmic puncta. Claudin-7
remained localized to the cytoplasm in puncta; sparse puncta
containing claudin-4 continued to be present. During lactation
both claudins-3 and -8 were localized to the tight junctions
where they are presumably responsible for the high level bar-
rier function of the epithelium. Claudin-7 continued to be
present in numerous cytoplasmic puncta while claudin-4 dis-
appeared entirely from the epithelium except for strong
basolateral localization in an occasional epithelial cell. In early
involution cytoplasmic claudins-3 and -4 came back robustly,
presumably as part of the wound healing response of the ep-
ithelium. Claudin-8 disappeared and claudin-7 continued its
cytoplasmic distribution. Claudin distribution during the in-
flammatory response was similar to that of early involution.
This descriptive summary of claudin distribution during
mammary development provides essential information neces-
sary for future investigations of many important questions:
1. What are the signaling mechanisms by which claudin
switching is developmentally regulated? It is clear from
studies of the effects of prolactin and dexamethasone on
claudin distribution in isolated mammary epithelial cells
[64], that claudins-3 and -4 respond to hormones in the
same manner as secreted proteins like casein, but the de-
tailed mechanisms of the hormone effects are not known.
2. What is the structure and function of the puncta contain-
ing non-junctional claudins? A start to answering this
question would be to analyze the proteins with which
the claudins interact, possibly using the biotin ligase tech-
nology so effectively utilized by the Anderson laboratory
in MDCK cells [39].
3. Are the non-junctional claudins involved in cell-cell and
cell-matrix interactions outside the tight junction?
Information supporting this possibility has been reviewed
in the introduction to this article.
b 
b
c d 
a
  CLDN3 CLDN4
     ZO-1  DAPI           ZO-1 DAPI
Developmental Stage 
Fig. 7 Claudins in mammary involution. a Levels of claudins-3 and -4
protein from Western blots during involution. Pups were removed from
day 10 lactating ICR mice. Dams were sacrificed at day 10 of lactation
and 1, 5 and 10 days later. Proteins from minced mammary glands were
electrophoresed and visualized with appropriate antibodies
(ThermoFisher) as described [43]. b Immunofluorescence of claudins-3
and -4 in the samples from panel a compared to localization of the tight
junction protein, occludin (OCLN). Images from Kobayashi lab after ref.
[43]. c,d Higher power images from sections of mammary glands from
10 day lactating FVB mice sacrificed 2 days after pup removal and
stained using antibodies for claudin-3, claudin-4 (claudins in red) and
the tight junction protein ZO-1 (green). Nuclei stained with DAPI
(blue) Significant cytoplasmic stain can be observed for both claudins
with little or no overlap with ZO-1. See methods for preparation of these
images from the Neville laboratory
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4. What are the mechanisms by which claudins facilitate the
wound healing process during involution that has been
suggested in the work from the Gusterson [48] and
Schedin [70] laboratories?
Importantly, the answers to these questions may also in-
crease our understanding of the roles of claudins-3, -4 and -7
in breast cancer, where high levels of expression, not associ-
ated with tight junctions, are often observed.
Materials and Methods for Unpublished
Experiments
Methods are Annotated by Figure Number
Figure 1. These figures were taken from the literature. The
original papers should be consulted for methods.
Figure 2a. Explicit methods are given in ref [29]. Briefly
female CD1 mice were sacrificed at various times during
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Fig. 8 Effect of LPS on amount,
type and localization of claudin
protein. a. Western blot of
claudins-1, −3, −4, and −7 in
10 day lactating gland 0, 3, 6, and
12 h after injection of E. coli
lipopolysaccharide (LPS) into the
teat canal of the fourth mammary
gland of ICR mice. b. Western
blot of claudins in Triton-X
soluble (S) and insoluble (P)
fractions of mammary gland
lysates after LPS injection. c.
Immunofluorescence analysis of
claudins in the mammary gland
12 h after injection of LPS.
Figures from ref. [31] Plos One
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the reproductive cycle, 4th mammary glands were flash
frozen after removal of the lymph node until homogeniza-
tion for mRNA analysis by quantitative real time PCR for
claudin-7 and murine cytokeratin 19, a marker of luminal
epithelial cells.
Figure 2b, c. Stein and colleagues [48] isolated mRNA
from the 4th mammary gland of 3 Balb/C mice each at 10
and 12 weeks of age, pregnancy days 1, 2, 3, 8.5, 12.5, 14.5
and 17.5, lactation days 1, 3, and 7 and involution days 1, 2, 3,
4, and 20 after forced weaning on lactation day 7. Rudolph
and colleagues [49] isolated mRNA from the 4th mammary
gland of 4 FVBmice each at six weeks of age, pregnancy days
1, 3, 7, 12, and 17 and lactation days 1, 2 and 9 and involution
on day 2 after forced weaning. Protocols for mRNA analysis
using Affymetrix Mu74Av2 microarray chips are detailed in
the original publications. The data were GC-RMA normalized
to correct for probeset-GC bias and raw expression values
plotted (i.e. GR-RMA normalized but not Log2 transformed
values, providing a rough estimate of mRNA expression am-
plitude). Raw data from glands isolated on similar days did not
differ between mice from the two experiments so the data
were combined when the time points overlapped.
Figure 3a Mammary gland collection: The third mamma-
ry gland on the left side of adult (>12 weeks) non-pregnant
non-lactating FVB mice (Jackson Laboratories, Bar Harbor,
Maine, USA) was dissected from mice euthanized by cervi-
cal dislocation after CO2 anesthesia; procedures were ap-
proved by the University of Colorado Animal Care and
Use Committee.
Figure 3 b–e, Fig. 4c–f, Fig. 5d, Fig. 7d–e.Mammary gland
Collection: CD-1 mice, purchased from Charles River
Breeding Laboratory (Wilmington, DE), were maintained in
the USDA approved Animal Resource Center of the
University of Colorado Health Sciences Center. All proce-
dures were approved by the Institutional Animal Care and
Use Committee. The fourth mammary glands of virgin female
mice at 3, 6, and 12 weeks of age, of female mice during early
gestation (7 days), mid-gestation (12 days) and late gestation
(18 days), at days 2 and 10 of lactation, and at day 2 involution
were collected after killing with a lethal dose of pentobarbital.
The day on which vaginal plugs were observed was counted
as day one of pregnancy. Paraffin sections were derived as
described in the previous section.
Figure 3 a–e, Fig. 4c–f, Fig. 5d, Fig. 7d–e. Preservation of
tissue and slide preparation. Half of each tissue piece was
placed in a cassette and submerged in phosphate buffered
saline (PBS) supplemented with 4% paraformaldehyde over-
night at 4 °C. Tissue cassettes were transported to the
University of Colorado Denver Research Histology Shared
Resource Facility for paraffin embedding, sectioning and de-
position on microscope slides.
Immunofluorescence. Slides were washed twice in xylene
for 20 min, twice in 100% ethanol for 3 min, and once in 90%,
70%, and 30% ethanol for 3 min each followed by washing in
PBS for 5 min before antigen retrieval with Antigen
Unmasking Solution (Vector Laboratories, Inc., Burlington,
CA, USA). Sections were submerged in the unmasking solu-
tion and brought to a boil 10 times with a 45 min rest between
each boil. After a 10 min cool-down and a 5 min wash in PBS,
sections were placed in a moist chamber and permeabilized
for 15 min with 1% TritonX-100 in PBS. Sections were rinsed
with PBS twice before blocking for 1 h in 10% normal donkey
serum in PBS supplemented with 100 μg/mL saponin.
Primary antibody was then applied overnight at 4 °C.
Primary antibodies included: rabbit anti-claudin-3 (1:200;
Invitrogen, Carlsbad, CA, USA), rabbit anti-claudin-4
(1:200; Invitrogen), mouse anti-claudin-4 (1:200;
Invitrogen), rabbit anti-claudin-7 (1:200; Invitrogen), mouse
anti-claudin-7 (1:200; Invitrogen). Sections were then washed
five times with PBS for 5 min before application of secondary
antibody or DAPI (5 μg/ml, MP Biochemicals, Solon, OH,
USA) for 45 min at room temperature. Secondary antibodies
were: donkey anti-rabbit conjugated to CY3, donkey anti-
mouse conjugated to FITC (all purchased from Jackson
ImmunoResearch Laboratories, West Grove, PA). Sections
were then washed five times with PBS before OPDA
(20 mg/ml, o-phenylenediamine dihydrochloride in 1 M
Tris, pH 8.5) was applied with a coverslip. Fluorescence was
imaged with an Olympus Spinning Disk confocal microscope
(University of Colorado AMC Light Microscopy Core).
Figure 4a, b. Mice: FVB mice were purchased from
Jackson Laboratories, Bar Harbor, Maine, USA and main-
tained in the laboratory. At 8 weeks of age or older mice were
bred; day 1 of pregnancy was defined as the day a postcoital
Fig. 9 Model for distribution of claudins between cytoplasm and
tight junctions at different stages of mammary development. See
text for explanation
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plug was observed. L1 was identified as the first day litters
were present. For Fig. 4a mammary glands were harvested
from dams at P14 and L2. For Fig. 4b and at P13.5, P17.5,
P 18.5, P19.5, during parturition and at L1, L2 and L9 . All
animal procedures were approved by the Institutional Animal
Care and Use Committee of the University of Colorado
Anschutz Medical Campus.
Figure 4a Mammary epithelial cell (MEC) isolation:
Adipose-depleted mouse MECs were isolated from the upper
inguinal glands as described [58] with modifications.
Specifically, after removal of lymph nodes, the mammary
glands were removed, minced, and digested with 1 mg/mL
collagenase type 1 (Worthington Biochemical Corporation,
LS004196) in Dulbecco’s Modified Eagle Medium: Nutrient
Mixture F-12 (HyClone, 11,330–032), for 80 min in a 37 °C
rotor. Collagenase was then quenched with 0.5% fetal bovine
serum, and the digested cell suspension was pelleted by cen-
trifugation. Erythrocytes were removed by successive washes
of the cell pellet in Dulbecco’s phosphate-buffered saline with
calcium and magnesium (Hyclone SH30264.01) followed by
2-s centrifugations at 1500 rpm until pellet was no longer red.
RNA isolation and hybridization: Total RNA was isolated
from MECs using Trizol solution (Thermo Fisher Scientific,
Waltham, MA, USA) and purified by Qiagen miRNA col-
umns (Qiagen, Venlo, Netherlands). RNA concentration and
purity were assessed in Applied Biosytems Bioanalyzer 2100
(Thermo Fisher Scientific). A 1 μg aliquot of total RNA from
each sample was labeled with FlashTag Biotin RNA Labeling
kit (Genisphere, Hatfield, PA, USA) and hybridized onto
GeneChip Mouse Gene 1.0 ST, GeneChip miRNA 1.0 ST
(Affymetrix, Santa Clara, CA, USA) according to the manu-
facturer’s recommendations and performed in the University
of Colorado Cancer Center Microarray Core Facility.
Affymetrix CEL files from all samples were loaded on to
Genespring GX10. Signal intensities for all probe sets were
obtained using Robust Multichip Averaging summarization
algorithm, involving three steps – background correction,
quantile normalization and probe summarization (median pol-
ish). Quality control was performed by principal component
analysis to identify outliers. Differentially expressed probe
sets between P14 and L2 were identified by performing an
unpaired t-test to obtain raw P-values, which were subse-
quently corrected by multiple testing using the BH-FDR
method. A 5% FDR cut-off was chosen to identify differen-
tially expressed probe sets. The raw data for the array used in
the microarray hybridization study are available at Gene
Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/
geo) under accession number GSE87584.
Figure 4b RNA isolation: Fourth mammary glands were
dissected from FVB mice, the lymph node removed, and the
tissues snap frozen in liquid nitrogen. Frozen samples were
pulverized and 100 mg was added to 1 mL of Trizol (Sigma
Aldrich, St. Louis, MO) and homogenized using a Brinkman
Polytron (www.brinkmann.com) on medium setting for 20–
45 s. Lysates were cleared at 13,000 x G for 10min at 4 °C and
the supernatant was collected. RNA was extracted according
to the manufacturer’s protocol. RNA pellets were resuspended
in 40–200 μL nuclease-free water (volume dependent on pel-
let size), and contaminants removed using the Qiagen RNeasy
mini Plus protocol according to manufacturer (kit # 74134).
Total RNAwas quantified using the Nanodrop 1000 spectro-
photometer (Life Technologies, Grand Island, NY). Total
RNA integrity was determined the Agilent 2100 Bioanalyzer
Nanoscale Microfluidics Chip Assay (Wilmington, DE).
cDNA Synthesis and Quantitative Real Time PCR: All re-
agents for cDNA synthesis were purchased from Applied
Biosystems (Foster City, CA). 1.0 μg of total RNAwas incubat-
edwith 2.5μL of 5.0 nmole randomhexamers at 65 °C for 5min
in a total volume of 11.5 μL. Samples were placed on ice and
then gently spun down. For each reaction tube, 10 μL of 25 mM
MgCl2, 5 μL of 10X PCR Buffer A, 5 μL of 2.5 mM dNTP
each, 1 μL of 20 units/μL RNAse Inhibitor, and 2.5 μL of
50 units/μL MMLV reverse transcriptase were mixed. 38.5 μL
of this master mix was added to each sample and mixed by
pipetting. AnAppliedBiosystemsGeneAmp9700 thermocycler
program was: 42 °C for 60 min, 95 °C for 5 min, and 4 °C hold.
Samples were placed on ice and spun down. Primer/probe sets
were designed using Primer Express software (Applied
Biosystems) and purchased from Integrated DNA
Technologies, Coralville, IA. 5 μL of cDNA (diluted 1:4) was
used as template in with 12.5 μL of 2× Universal Master Mix,
2.5 μL 20× primer/probe mix (5 μM primers, 2.5 μM probe),
and 5 μL nuclease free water to make a total reaction volume of
25.0 μL. See Additional File 1 for primers and probe sets used.
Figure 4a Statistics:Data are presented asMean ± Standard
Error of the Mean (s.e.m.) with four samples per time point.
An unpaired Student t test was used for statistical comparison
between P14 and L2 groups. A p value of <0.05 was consid-
ered significant.
Methods for the images from the Kobayashi are given in
the relevant articles.
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